ArticleMolecular therapy. Oncology2025

Aurora kinase A drives non-canonical YAP1/TAZ crosstalk to sustain primary resistance to anti-EGFR therapies in colorectal cancer.

Anxo Rio-Vilariño et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.